Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome
That review is separate from the July meeting
Semaglutide works by mimicking GLP-1, a hormone that helps control blood sugar levels by causing the pancreas to release insulin, decreasing the production of glucagon, and slowing down the emptying of the stomach
This dual action results in improved glycemic control and significant weight reduction
The maintenance phase demonstrates whether achieved benefits persist with reduced intensity protocols or whether more aggressive approaches are necessary to sustain improvements
The peptide is typically administered as a subcutaneous injection and can be delivered in-office or as part of our concierge home service in Beverly Hills, Los Angeles, and surrounding areas